Verbeek J - Search Results

1

Editorial overview: The treatment of liver diseases in 2020-2030.

Tsochatzis EA, Verbeek J. Tsochatzis EA, et al. Among authors: verbeek j. Curr Opin Pharmacol. 2022 Feb;62:1-3. doi: 10.1016/j.coph.2021.10.007. Epub 2021 Nov 30. Curr Opin Pharmacol. 2022. PMID: 34861629 No abstract available.

2

Treatment of severe alcoholic hepatitis: A systematic review.

Van Melkebeke L, Korf H, Tsochatzis EA, van der Merwe S, Nevens F, Verbeek J. Van Melkebeke L, et al. Among authors: verbeek j. Curr Opin Pharmacol. 2021 Oct;60:91-101. doi: 10.1016/j.coph.2021.06.011. Epub 2021 Aug 5. Curr Opin Pharmacol. 2021. PMID: 34365226 Review.

3

Non-alcoholic fatty liver disease: Current therapeutic options.

Majumdar A, Verbeek J, Tsochatzis EA. Majumdar A, et al. Among authors: verbeek j. Curr Opin Pharmacol. 2021 Dec;61:98-105. doi: 10.1016/j.coph.2021.09.007. Epub 2021 Oct 21. Curr Opin Pharmacol. 2021. PMID: 34688168 Review.

4

Treatment of non-alcoholic fatty liver disease: can we already face the epidemic?

Verbeek J, Cassiman D, Lannoo M, Laleman W, van der Merwe S, Verslype C, Van Steenbergen W, Nevens F. Verbeek J, et al. Acta Gastroenterol Belg. 2013 Jun;76(2):200-9. Acta Gastroenterol Belg. 2013. PMID: 23898557 Free article. Review.

5

De novo Malignancy and Recurrent Alcoholic Cirrhosis Account for 70% of Deaths in Patients Transplanted for End-Stage Alcoholic Liver Disease.

Verbeek J, Cassiman D, Nevens F. Verbeek J, et al. Am J Gastroenterol. 2016 Mar;111(3):436-7. doi: 10.1038/ajg.2016.10. Am J Gastroenterol. 2016. PMID: 27018119 No abstract available.

6

An Overview of Mouse Models of Nonalcoholic Steatohepatitis: From Past to Present.

Jacobs A, Warda AS, Verbeek J, Cassiman D, Spincemaille P. Jacobs A, et al. Among authors: verbeek j. Curr Protoc Mouse Biol. 2016 Jun 1;6(2):185-200. doi: 10.1002/cpmo.3. Curr Protoc Mouse Biol. 2016. PMID: 27248434 Review.

7

Intestinal permeability in human nonalcoholic fatty liver disease: A systematic review and meta-analysis.

De Munck TJI, Xu P, Verwijs HJA, Masclee AAM, Jonkers D, Verbeek J, Koek GH. De Munck TJI, et al. Among authors: verbeek j. Liver Int. 2020 Dec;40(12):2906-2916. doi: 10.1111/liv.14696. Epub 2020 Oct 21. Liver Int. 2020. PMID: 33037768 Free PMC article. Review.

8

Improved Markers of Cholestatic Liver Injury in Patients With Primary Biliary Cholangitis Treated With Obeticholic Acid and Bezafibrate.

Smets L, Verbeek J, Korf H, van der Merwe S, Nevens F. Smets L, et al. Among authors: verbeek j. Hepatology. 2021 Jun;73(6):2598-2600. doi: 10.1002/hep.31613. Epub 2021 May 25. Hepatology. 2021. PMID: 33140868 No abstract available.

9

A long-term study of liver-related events in Caucasian hepatitis B patients with normal ALT values and high viremia.

Koc ÖM, Verbeek J, Koek GH, Bielen R, Busschots D, Gamil M, Robaeys G, Nevens F. Koc ÖM, et al. Among authors: verbeek j. Acta Gastroenterol Belg. 2022 Jan-Mar;85(1):56-61. doi: 10.51821/85.1.9160. Acta Gastroenterol Belg. 2022. PMID: 35304994 Free article.

10

Comparison of the single-cell and single-nucleus hepatic myeloid landscape within decompensated cirrhosis patients.

Van Melkebeke L, Verbeek J, Bihary D, Boesch M, Boeckx B, Feio-Azevedo R, Smets L, Wallays M, Claus E, Bonne L, Maleux G, Govaere O, Korf H, Lambrechts D, van der Merwe S. Van Melkebeke L, et al. Among authors: verbeek j. Front Immunol. 2024 Feb 6;15:1346520. doi: 10.3389/fimmu.2024.1346520. eCollection 2024. Front Immunol. 2024. PMID: 38380322 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

535 results

Search Page